234080.KS
JW Lifescience Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 11,200.00
−1.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 6.37x
- P/E 2027E
- 5.96x
- P/E 2028E
- 5.56x
- P/S forward
- 1.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- 6.66x
- PEG TTM
- 0.60x
- Price / book
- 0.76x
- Price / sales
- 0.68x
- Price / cash flow
- 3.61x
Enterprise value
- Enterprise value
- KRW 196.4B
- EV / sales
- 0.77x
- EV / EBITDA
- 3.79x
- EV / EBIT
- 5.89x
- Market cap
- KRW 173.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026